You are here

  • Home
  • Archive
  • Volume 30, Issue 7
  • Real world outcomes in platinum sensitive relapsed ovarian, fallopian tube, or peritoneal cancer treated in routine clinical practice in the United Kingdom prior to poly-ADP ribose polymerase inhibitors

Citation Tools

Article menu
Download PDFPDF
Original research
Real world outcomes in platinum sensitive relapsed ovarian, fallopian tube, or peritoneal cancer treated in routine clinical practice in the United Kingdom prior to poly-ADP ribose polymerase inhibitors

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Lord R, Rauniyar J, Morris T, et al
Real world outcomes in platinum sensitive relapsed ovarian, fallopian tube, or peritoneal cancer treated in routine clinical practice in the United Kingdom prior to poly-ADP ribose polymerase inhibitors
International Journal of Gynecologic Cancer 2020;30:1026-1033.